Sino-Argi Leading Biosciences (603970) — Strategic Asset Allocation Index
Sino-Argi Leading Biosciences (603970) has a Strategic Asset Allocation Index of 4.6% as of June 2023. Strategic assets (PP&E of CN¥71.11 Million plus long-term investments of CN¥-) total CN¥71.11 Million, measured against net assets of CN¥1.53 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Sino-Argi Leading Biosciences Strategic Asset Allocation Index (2012–2022)
This chart shows how Sino-Argi Leading Biosciences's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 4.6%, representing strategic assets of CN¥71.11 Million against net assets of CN¥1.53 Billion CNY. Explore cash efficiency ratio of Sino-Argi Leading Biosciences to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Sino-Argi Leading Biosciences (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sino-Argi Leading Biosciences from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Sino-Argi Leading Biosciences market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 4.1% | CN¥60.39 Million | CN¥60.39 Million | CN¥- | CN¥1.48 Billion | ▼ -1.7 pp |
| 2021 | 5.8% | CN¥73.77 Million | CN¥73.77 Million | CN¥- | CN¥1.28 Billion | ▲ +2.1 pp |
| 2020 | 3.7% | CN¥42.06 Million | CN¥42.06 Million | CN¥- | CN¥1.14 Billion | ▲ +0.3 pp |
| 2019 | 3.4% | CN¥35.34 Million | CN¥35.34 Million | CN¥- | CN¥1.04 Billion | ▼ -0.8 pp |
| 2018 | 4.2% | CN¥40.12 Million | CN¥40.12 Million | CN¥- | CN¥957.07 Million | ▼ -1.6 pp |
| 2017 | 5.8% | CN¥50.51 Million | CN¥50.51 Million | CN¥- | CN¥866.35 Million | ▼ -9.3 pp |
| 2016 | 15.1% | CN¥65.07 Million | CN¥65.07 Million | CN¥- | CN¥431.42 Million | ▲ +2.0 pp |
| 2015 | 13.1% | CN¥45.24 Million | CN¥45.24 Million | CN¥- | CN¥344.56 Million | ▲ +5.6 pp |
| 2014 | 7.6% | CN¥22.01 Million | CN¥22.01 Million | CN¥- | CN¥290.44 Million | ▼ -0.8 pp |
| 2013 | 8.3% | CN¥21.90 Million | CN¥21.90 Million | CN¥- | CN¥262.68 Million | ▼ 0.0 pp |
| 2012 | 8.3% | CN¥20.15 Million | CN¥20.15 Million | CN¥- | CN¥241.63 Million | — |